Sir Philip Cohen delivered the 2013 McCormick Lecture entitled, "Novel Signalling Networks that Prevent the Development of Autoimmune and Inflammatory Diseases"
Sir Philip Cohen, Fellow of the Royal Society, gave the McCormick Lecture on April 8, 2013. His lecture title was, “Novel Signalling Networks that Prevent the Development of Autoimmune and Inflammatory Diseases".
A Fellow of the Royal Society, Sir Philip Cohen pioneered the field of “protein phosphorylation,” a biological control mechanism that regulates most aspects of cell life. He discovered several enzymes that have subsequently been targeted to develop drugs for the treatment of cancer and rheumatoid arthritis and to prevent tissue rejection after organ transplantation. He determined how insulin converts blood glucose to its storage form glycogen. His current research is focused on understanding how the innate immune system works.
Sir Philip is a foreign Associate of the National Academy of Sciences and Professor of Enzymology, Medical Research Council Protein Phosphorylation Unit, University of Dundee, Scotland. He received BSc and PhD degrees from University College, London and held an SRC/NATO postdoctoral fellowship at the University of Washington, Seattle, before joining the University of Dundee, Scotland in 1971, where he has worked ever since. He was a Royal Society research professor from 1984-2010, director of the Medical Research Council Protein Phosphorylation Unit from 1990-2012, and director of the Scottish Institute for Cell Signaling from 2008-2012. He co-directs the Division of Signal Transduction Therapy, Europe’s largest collaboration between academia and the pharmaceutical industry, which received a Queen’s Anniversary Award for Higher Education in 2006.
Sir Philip’s awards include the Swiss Louis Jeantet Prize for Medicine, the Prix Van Gysel of the Belgian Royal Academy of Medicine, the Pfizer Award for Innovative Science in Europe, the Bristol Myers Squibb Distinguished Achievement Award in Metabolic Research and the Rolf Luft Prize of the Karolinska Institute, Sweden. Knighted in 1998, he was elected Fellow of the Royal Society of Edinburgh and Fellow of the Royal Society of London in 1984, receiving their Royal Medals in 2005 and 2008, respectively, and he was made a Foreign Associate of the US National Academy of Sciences in 2008.
Past McCormick Lecture Speakers Have Been:
Hector DeLuca, Ph.D., Steenbock Research Professor in the Department of Biochemistry at the University of Wisconsin-Madison
Michael R Waterman, Ph.D., Professor of Biochemistry, Natalie Overall Warren Distinguished Chair in Biochemistry, Vanderbilt
Randy Schekman, PhD, Howard Hughes Investigator and Professor of Cell and Developmental Biology, UC Berkeley
Venki Ramakrishnan, PhD, Nobel Laureate 2009; Group Leader, MRC Laboratory of Molecular Biology, Cambridge, United Kingdom
Roger Y. Tsien, PhD, Nobel Laureate 2008, Howard Hughes Medical Institute Investigator, Professor of Pharmacology, Chemistry & Biochemistry, UCSD